What this Trial Is About

This research focuses on patients who underwent autonomic and enteric profiling called Adrenergic Cholinergic Enteric Measures/Mapping (ACEM) at the University of Louisville between 2012 and 2019. The study aims to evaluate ACEM's results by comparing them to standardized gastric emptying values as the primary measurement. Additionally, ACEM findings are compared with metabolic measures such as weight, height, and body mass index (BMI), as well as traditional patient-reported gastrointestinal symptoms as secondary measures. The study uses existing data from patients who had ACEM testing performed, with no new interventions or treatments described. While the primary focus is on the physiological and metabolic assessments, the study may include other sites if they have appropriate data sharing agreements with the University of Louisville. There are no specific treatment groups or dosing schedules involved. Participants' involvement centers around their recorded clinical and physiological data, including autonomic and enteric profiles, gastric emptying values, and metabolic information like BMI. The primary outcome measured is body mass index tracked over 10 years. Gastrointestinal symptoms reported by patients are also evaluated. This study uses retrospective data and does not describe active monitoring or follow-up visits.

Adrenergic Cholinergic Enteric Measures/Mapping